Screening selected blood donors with biochemical iron overload for hemochromatosis: A regional experience

Haematologica

Volumn 89, Issue 10, 2004, Pages 1161-1167

  De Gobbi, Marco ^a   D'Antico, Sergio ^b   Castagno, Franco ^b   Testa, Domenico ^c   Merlini, Roberta ^a   Bondi, Alessandro ^a   Camaschella, Clara ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UO Ostetricia e Ginecologia   (Italy)

Author keywords

Blood donors; Hemochromatosis; HFE; Screening

Indexed keywords

FERRITIN; HFE PROTEIN; TRANSFERRIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD DONOR; BODY MASS; COST EFFECTIVENESS ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERFERRITINEMIA; IRON OVERLOAD; ITALY; MALE; PREVALENCE; SCREENING;

ADULT; ALCOHOL DRINKING; AMINO ACID SUBSTITUTION; BLOOD DONORS; DNA MUTATIONAL ANALYSIS; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON OVERLOAD; ITALY; MALE; MASS SCREENING; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; PHENOTYPE; POINT MUTATION; QUESTIONNAIRES; TRANSFERRIN;

EID: 6344223437     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Camaschella C, De Gobbi M, Roetto A. Hereditary hemochromatosis: progress and perspective. Rev Clin Exp Hematol 2000;4:302-21.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative hemochromatosis mutations. J Med Genet 1997;34:275-8.
4. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-32.
5. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Ludica L, Montosi G, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;81:996-1002.
6. Borot N, Roth M, Malfroy L, Demangel C, Vinel JP, Pascal JP, et al. Mutations in the MHC class l-like candidate gene for hemochromatosis in French patients, Immunogenetics 1997;845:320-4.
7. Papanikolau G, Politou M, Terpos E, Four-lemadis S, Sakellaropoulos N, Loukopoulos D. Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol Dis 2000; 26:163-8.
8. Cardoso CS, Oliveira P, Porto G, Oberkanins C, Mascarenhas M, Rodrigues P, et al. Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal. Eur J Hum Genet 2001;9: 843-8.
9. Wallace DF, Dooley JSE, Walker AP. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology 1999;116:1409-12.
10. Piperno A, Arosio C, Fossati L, Vigano M, Trombini P, Vergani A, et al. Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 2000;119:441-5.
11. Oberkanins C, Moritz A, de Villiers JN, Kotze MJ, Kury F. A reverse-hybridization assay for the rapid and simultaneous detection of nine HFE gene mutations Genet Test 2000;4:121-4.
12. Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJ. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet Test 2000; 4: 151-61.
13. Camaschella C, Roetto A, Cali' A, De Gobbi M, Garozzo G, Carella M, et al. The gene encoding transferrin receptor 2 is mutated in a new type of hemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5.
14. Roetto A, Totano A, Piperno A, Piga A, Longo F, Garozzo G, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001; 97: 2555-60.
15. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-4.
16. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108: 619-23.
17. Roetto A, Papanikoalou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-2.
18. Roetto A, Daraio F, Porporato P, Caruso R, Cox TM, Cazzola M, et al. Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood 2004;103:2407-9.
19. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
20. Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, et al. The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004;103:4317-21.
21. Lee PL, Beutler E, Rao SV, Barton JC, Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 2004; 103: 4669-71.
22. De Gobbi M, Barilaro MR, Garozzo G, Sbaiz L, Alberti F, Camaschella C. TFR2 Y250X mutation in Italy. Br J Haematol 2001;114:243-4.
23. Devalia V, Carter K, Walker AP, Perkins SJ, Worwood M, May A, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002;100:695-7.
24. Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW, et al. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 2002;100:692-4.
25. Roetto A, Merryweather-Clarke AT, Daraio F, Livesey K, Pointon JJ, Barbabietola G, et al. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4? Blood 2002,100: 733-4.
26. Cazzola M, Cremonesi L, Papaioannou M, Soriani N, Kioumi A, Charalambidou A, et al. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br J Haematol 2002;119:539-46.
27. Restagno G, Gomez AM, Sbaiz L, De Gobbi M, Roetto A, Bertino E, et al. A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. Genet Test 2000;4:177-81.
28. De Gobbi M, Daraio F, Oberkanins C, Moritz A, Kury F, Fiorelli G, et al. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload. Haematologica 2003;88:396-401.
29. Godard B, ten Kate L, Evers-Kiebooms G, Ayme S. Population genetic screening programmes: principles, techniques, practices, and policies. Eur J Hum Genet 2003;11 Suppl 2:S49-87.
30. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G>A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
31. Adams PC. Population screening for hemochromatosis - are we finding people with a disease or a biochemical curiosity? Semin Gastrointest Dis 2002; 13:89-94.
32. Ajioka RS, Kushner JP. Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 2003; 101: 3351-3.
33. Cassanelli S, Pignatti E, Montosi G, Garuti C, Mariano M, Campioli D, et al. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol 2001 ;34:523-8.
34. Barosi G, Salvaneschi L, Grasso M, Martinetti M, Marchetti M, Bodini U, et al. High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy. Haematologica 2002;87:472-8.
35. Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, et al. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation. Hematol J 2003;4:436-40.
36. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
37. Triadou P, Regnat-Lusinchi A, Girot R. Use of ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage. Eur J Haematol 1989;43:413-27.
38. Deugnier Y, Jouanolle AM, Chaperon J, Moirand R, Pithois C, Meyer JF, et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol 2002; 118: 1170-8.
39. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Mutton RD, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001;114:474-84.
40. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
41. Adams PC. Population screening for haemochromatosis. Gut 2000;46:301-3.
42. McGrath JS, Deugnier Y, Moirand R, Jouanolle AM, Chakrabarti S, Adams PC. A normogram to predict C282Y hemochromatosis. J Lab Clin Med 2002;140:6-8.
43. Njajou OT, Alizadeh BZ, van Duijn CM. Is genetic screening for hemochromatosis worthwhile? Eur J Epidemiol 2004; 19: 101-8.
44. Cazzola M. Hereditary hyperferritinaemia/cataract syndrome. Best Pract Res Clin Haematol 2002;15:385-98.
45. Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 2003;102:1904-10.
46. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-7.
47. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-63.
48. Salvioni A, Mariani R, Oberkanins C, Moritz A, Mauri V, Pelucchi S, et al. Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry. Haematologica 2003;88:250-5.
49. Pozzato G, Zorat F, Nascimben F, Gregorutti M, Comar C, Baracetti S, et al. Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. Eur J Hum Genet 2003;9:445-51.
50. Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O'Leary MT, Braggins C, et al. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 1998;129:954-61.
51. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328:1616-20.
52. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-5.
53. Menardi G, Perotti L, Prucca M, Martini S, Prandi G, Peano G. A very rare association of three mutations of the HFE gene for hemochromatosis. Genet Test 2002; 6: 331-4.
54. Sanchez AM, Schreiber GB, Bethel J, McCurdy PR, Glynn SA, Williams AE, et al. Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis. Retrovirus Epidemiology Donor Study (REDS). JAMA 2001; 286: 1475-81.
55. Leitman SF, Browning JN, Yau YY, Mason G, Klein HG, Conry-Cantilena C, et al. Hemochromatosis subjects as allogeneic blood donors: a prospective study. Transfusion 2003;43:1538-44.
56. Mariani R, Salvioni A, Corengia C, Erba N, Lanzafame C, De Micheli V, et al. Prevalence of HFE mutations in upper Northern Italy: study of 1132 unrelated blood donors. Drug Liver Dis 2003; 35: 479-81.
57. Pietrapertosa A, Vitucci A, Campanale D, Palma A, Renni R, Delios G, et al. HFE gene mutations an Apulian population: allele frequencies. Eur J Epidemiol 2003; 18:685-9.
58. Melis MA, Cau M, Congiu R, Ruvoletto L, Cao A, Galanello R. Frequency of hemochromatosis C282Y and H63D mutations in Sardinia. Genet Test 2002;6:327-9.
59. Candore G, Mantovani V, Balistreri CR, Lio D, Colonna-Romano G, Cerreta V, et al. Frequency of the HFE gene mutations in five Italian populations. Blood Cells Mol Dis 2002;29:267-73.